荧光素二醋酸染色痰涂片预测结核病传染性
研究评估荧光素二醋酸(FDA)染色痰涂片预测结核病传染性的价值,对35例肺结核患者治疗前痰标本行FDA显微镜检查、培养和抗酸染色,并随访其209名家庭接触者6年。结果显示,治疗前痰中FDA染色阳性菌浓度低于中位数的患者,其接触者结核病发病率显著高于FDA染色阳性菌浓度高于中位数的患者(10% vs 2.7%),提示FDA染色阴性菌反而与更高传染性相关。
要点
- FDA染色阳性菌浓度低于中位数的患者,其接触者结核病发病率更高(10% vs 2.7%)。
- FDA染色阴性菌可能是一种不染色、缓慢代谢且更适应空气传播的表型。
- FDA染色痰涂片或可辅助预测结核病传染性,但需进一步验证。
核心结论
- 治疗前痰中FDA染色阴性菌反而与更高的结核病传染性相关。
研究设计与样本
- 前瞻性队列研究,纳入35例肺结核患者,随访其209名家庭接触者6年。
主要发现
- FDA染色阳性菌中位浓度为119(IQR 47-386)个/µL痰,为抗酸染色阳性菌浓度(2069 [IQR 1358-3734] 个/µL)的5.1%(IQR 2.4%-11%)。
- 随访期间209名接触者中13名(6.4%)诊断为结核病。
临床怎么用
- FDA染色痰涂片可能有助于识别高传染性结核病患者,但尚需进一步研究确认。
局限性
- 样本量较小(35例患者),随访接触者209名,可能限制统计效能和普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sputum from patients with tuberculosis contains subpopulations of metabolically active and inactive Mycobacterium tuberculosis with unknown implications for infectiousness. METHODS: We assessed sputum microscopy with fluorescein diacetate (FDA, evaluating M. tuberculosis metabolic activity) for predicting infectiousness. Mycobacterium tuberculosis was quantified in pretreatment sputum of patients with pulmonary tuberculosis using FDA microscopy, culture, and acid-fast microscopy. These 35 patients' 209 household contacts were followed with prevalence surveys for tuberculosis disease for 6 years. RESULTS: FDA microscopy was positive for a median of 119 (interquartile range [IQR], 47-386) bacteria/µL sputum, which was 5.1% (IQR, 2.4%-11%) the concentration of acid-fast microscopy-positive bacteria (2069 [IQR, 1358-3734] bacteria/μL). Tuberculosis was diagnosed during follow-up in 6.4% (13/209) of contacts. For patients with lower than median concentration of FDA microscopy-positive M. tuberculosis, 10% of their contacts developed tuberculosis. This was significantly more than 2.7% of the contacts of patients with higher than median FDA microscopy results (crude hazard ratio [HR], 3.8; P = .03). This association maintained statistical significance after adjusting for disease severity, chemoprophylaxis, drug resistance, and social determinants (adjusted HR, 3.9; P = .02). CONCLUSIONS: Mycobacterium tuberculosis that was FDA microscopy negative was paradoxically associated with greater infectiousness. FDA microscopy-negative bacteria in these pretreatment samples may be a nonstaining, slowly metabolizing phenotype better adapted to airborne transmission.
引用
- Datta S, Sherman JM, Tovar MA, et al. Sputum Microscopy With Fluorescein Diacetate Predicts Tuberculosis Infectiousness. J Infect Dis. 2017. PMID: 28510693. doi:10.1093/infdis/jix229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。